EAM
ABBV icon

Eventide Asset Management’s AbbVie ABBV Stock Holding History

Eventide Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,000
Closed -$378K – 135
2018
Q3 		$378K Sell
4,000
-443,000
-99% -$42M 0.01% 143
2018
Q2 		$41.4M Hold
447,000
– – 1.72% 14
2018
Q1 		$42.3M Hold
447,000
– – 1.98% 10
2017
Q4 		$43.2M Sell
447,000
-107,500
-19% -$10.1M 2.25% 9
2017
Q3 		$49.3M Sell
554,500
-3,000
-0.5% -$228K 2.79% 4
2017
Q2 		$40.4M Buy
557,500
+2,200
+0.4% +$148K 2.52% 7
2017
Q1 		$36.2M Sell
555,300
-285,100
-34% -$17.9M 2.4% 8
2016
Q4 		$52.6M Buy
840,400
+5,200
+0.6% +$317K 3.42% 2
2016
Q3 		$52.7M Buy
835,200
+5,550
+0.7% +$359K 3.22% 4
2016
Q2 		$51.4M Buy
829,650
+3,198
+0.4% +$195K 3.14% 6
2016
Q1 		$47.2M Sell
826,452
-27,023
-3% -$1.51M 2.64% 8
2015
Q4 		$50.6M Buy
853,475
+32,150
+4% +$1.85M 2.53% 9
2015
Q3 		$44.7M Buy
821,325
+37,025
+5% +$2.41M 2.6% 7
2015
Q2 		$52.7M Buy
784,300
+407,200
+108% +$26.6M 2.85% 3
2015
Q1 		$22.1M Buy
377,100
+46,400
+14% +$2.8M 1.66% 20
2014
Q4 		$21.6M Hold
330,700
– – 2.36% 7
2014
Q3 		$19.1M Buy
330,700
+38,000
+13% +$2.11M 2.67% 5
2014
Q2 		$16.5M Buy
292,700
+4,900
+2% +$257K 2.25% 6
2014
Q1 		$14.8M Buy
287,800
+139,300
+94% +$7.04M 2.3% 5
2013
Q4 		$7.84M Buy
+148,500
New +$7.3M 2.42% 4

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Eventide Asset Management's ABBV Position: Q4 2018 in Review

Eventide Asset Management sold out of AbbVie (ABBV) in Q4 2018, closing a stake of 4,000 shares — an estimated $378K sold.

Eventide Asset Management first reported a position in ABBV in Q4 2013 and held it in 20 quarters. The position peaked at $52.7M in Q2 2015. 2,063 funds tracked by Wall St. Rank hold ABBV as of Q4 2018.

  • Eventide Asset Management reported no remaining AbbVie position as of Q4 2018 after selling out during the quarter.
  • Eventide Asset Management sold 4,000 AbbVie shares in Q4 2018, an estimated $378K.
  • Eventide Asset Management first reported a position in AbbVie in Q4 2013 and held it in 20 quarters.
  • Eventide Asset Management's AbbVie position peaked at $52.7M in Q2 2015.
  • 2,063 funds tracked by Wall St. Rank held AbbVie as of Q4 2018.

Based on Eventide Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.